The largest database of trusted experimental protocols

7 protocols using 14c cholesterol

1

Cholesterol Efflux Assay for Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipid efflux assays were performed as previously described (Lyssenko et al., 2013 (link)). Twenty days after differentiation, HLCs were radiolabeled, with 0.12 μCi/ml 14C-cholesterol and 1.3 μCi/ml 3H-choline or with 0.12 μCi/ml 14C-cholesterol only (PerkinElmer, Waltham, MA, USA) in the presence of T0901317 (10 μM, Sigma-Aldrich T2320) for 24 h. Cells were then washed twice and incubated in fresh medium with or without exogenous human apoA-I (20 μg/ml) for 6 h. At the end of incubation, cell medium was collected and filtered through a 96-well filter plate (EMD Millipore) to remove cell debris. ApoB-containing lipoprotein was precipitated using phosphotungstate. Remaining HDL-containing medium underwent lipid extraction by Bligh-Dyer method. Cellular lipids were extracted with hexane-isopropanol (3:2, v/v) and the solvent was then evaporated for scintillation counting. The percentage of cholesterol export was calculated by dividing the 14C counts in the medium by the sum of counts in the medium and cells and multiplying by 100.
+ Open protocol
+ Expand
2

Cholesterol Metabolism and Regulation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deuterated sterols were purchased from Medical Isotopes Inc. Radiolabeled sterols, including [3H]cholesterol, [3H]cholesteryl oleate, and [14C]cholesterol, were purchased from PerkinElmer Inc. Bile acid levels and phospholipids were measured using kits from Crystal Chem Inc. and Wako Chemicals USA Inc., respectively. Abs against mouse G5 and G8 were developed as previously described (11 (link)); Abs against ABCA1 were purchased from Pierce Biotechnology Inc. All other Abs, including polyclonal Abs against low density lipoprotein receptor (LDLR) and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and monoclonal Abs against sterol-regulatory element binding protein (SREBP) 1 and SREBP-2 were gifts from Guosheng Liang (University of Texas Southwestern Medical Center).
+ Open protocol
+ Expand
3

Bryonolic Acid Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bryonolic acid (BrA) was purified and characterized exactly as described earlier [5 (link)]. Betulinic and ursolic acids were purchased from Extrasynthese (Lyon Nord, Genay, France). Acetic acid, acetonitrile, dichloromethane (DCM) and anhydrous sodium sulphate were obtained from Merck (Darmstadt, Germany). 3-[decyldimethylsilyl]-N-[2-(4-methylphenyl)-1-phenylethyl]-propanamide (Sah 58-035) was kindly provided by A. Suter at Novartis (Basel, Switzerland). [3H]17βEstradiol, [14C]oleyl-CoA and [14C] cholesterol were from Perkin Elmer (Waltham, MA, USA). The radiochemical purity of the compounds was verified by thin-layer chromatography (TLC) and was greater than 98%. Solvents were from Sigma, Fischer, Scharlau or VWR. TLC plates were from Macherey Nagel. Normal silica Sep-Pack cartridges were from Waters. All other chemicals and reagents were purchased from Sigma-Aldrich (Saint-Louis, MO, USA).
+ Open protocol
+ Expand
4

Cholesterol Efflux Assay with ApoA-IV

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were loaded with cholesterol by incubation for 48 h with acetylated LDL (50 μg of protein/mL) and 14C-cholesterol (0.3 uCi/mL, Perkin Elmer, Boston, MA) then incubated with DMEM containing fatty acid-free bovine serum albumin (BSA) for 24 h to equilibrate cell cholesterol pools. The cells were then incubated for 8 h with unmodified-apoA-IV or AGE-apoA-IV (30 μg/mL). Radioactivity was measured in the medium and in the cells. The % cholesterol efflux was calculated as described by Machado et al. [47 (link)].
+ Open protocol
+ Expand
5

Cholesterol Metabolism Reagents Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals were purchased from Sigma: angiotensin II (cat # A9525), dexamethasone (cat # D4902), dibutyryl cyclic-AMP sodium salt (cat # D0627), forskolin (cat # F6886), glucagon (cat # G2044), hydrocortisone (cat # H0888), InSolution H-89 dihydrochloride (cat # 371962), PKA Inhibitor 14-22 Amide (cat # 476485), and tyloxapol (cat # T0307). 14C-cholesterol (cat # NEC018050UC), 3H-cholesterol (cat # NET139001MC), 3H-cholesteryl oleate (cat # NET746L001MC) and 3H-triolein (cat # NET431001MC) were purchased from PerkinElmer.
+ Open protocol
+ Expand
6

Nascent HDL Formation and Gel-Filtration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nascent HDL formation and gel-filtration chromatography analysis of nascent HDL were performed as previously described (Lyssenko et al., 2013 (link)). Briefly, HLCs were dual radiolabeled with 1.3 μCi/ml 3H-choline and 0.12 μCi/ml 14C-cholesterol (PerkinElmer, Waltham, MA, USA) in the presence of 10 μM T0901317 (Sigma-Aldrich T2320) for 24 h. After two washes, efflux medium with or without human apoAI (20 μg/ml) were added to cells for a 6-hour incubation. Cell medium was collected, filtered through a 0.45 μm PVDF membrane filter unit (EMD Millipore), and concentrated using Amicon Ultracel-10 K centrifugal filters (EMD Millipore). A 1-ml aliquot of the concentrated cell medium was resolved into 1-ml fractions on a calibrated HiLoad 16/60 Superdex 200 gel-filtration column (GE Healthcare, Mickleton, NJ, USA). 3H and 14C counts in each fraction were determined by scintillation counting. Results were presented as counts per fraction for regions containing HDLs (fraction 45–90).
+ Open protocol
+ Expand
7

Cholesterol Metabolism Reagents Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals were purchased from Sigma: angiotensin II (cat # A9525), dexamethasone (cat # D4902), dibutyryl cyclic-AMP sodium salt (cat # D0627), forskolin (cat # F6886), glucagon (cat # G2044), hydrocortisone (cat # H0888), InSolution H-89 dihydrochloride (cat # 371962), PKA Inhibitor 14-22 Amide (cat # 476485), and tyloxapol (cat # T0307). 14C-cholesterol (cat # NEC018050UC), 3H-cholesterol (cat # NET139001MC), 3H-cholesteryl oleate (cat # NET746L001MC) and 3H-triolein (cat # NET431001MC) were purchased from PerkinElmer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!